- Wedbush analyst Gerald Pascarelli initiated coverage on Cresco Labs Inc CRLBF with an Outperform rating and a price target of $4.50.
- The company awaits the closing of the Columbia Care CCHWF acquisition, which is expected to occur by the end of 1Q23 and should prove transformative.
- He expects standalone revenue growth to re-accelerate in the coming year on more favorable comparable sales as well as an outlook for better trends in key states.
- With the stock off about 80% from peak levels, Pascarelli believes that the selloff is overdone and that Cresco’s shares are undervalued.
- While he expects scale, market share and whitespace to be the initial focus, the company will need to demonstrate the ability to cut costs post close, as CCHWF will be margin dilutive to the combined company at the outset.
- Wedbush analyst Gerald Pascarelli also initiated coverage on Curaleaf Holdings Inc CURLF with an Outperform rating and a price target of $8.50.
- Curaleaf is the largest cannabis operator in the U.S. and should be well positioned to realize incremental benefits from the rollout of adult use sales in new states in addition to benefitting from better performance in the many legacy markets to which it is exposed, the analyst noted.
- The analyst expects the company to be a net market share gainer and outpace the broad industry.
- An expected reduction in spending should position the company to reap the benefits from a historical capital intensive investment cycle and importantly protect its cash position, Pascarelli added.
- Price Action: CRLBF shares are trading higher by 4.70% at $3.717, and CURLF shares are trading higher by 0.28% at $7.04 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.